Amarin Corp. PLC AMRN, +2.63% followed through on Wednesday, up 55 cents to $21.49 after popping 23% on Tuesday. An FDA advisory committee is scheduled to meet today to help decide the fate of the company’s fish-derived cardiovascular drug. While trading has been halted this morning in advance of the meeting, the chart points to a test of the July high in the $23.50-$24.00 zone next.
AMD, Amarin and Crispr are three stocks to watch for potentially higher prices
Someone on ST posted that the bid was $25 and the ask is $26.27.
I might be in an order to sell a few shares at $30 and $35.
AMD, Amarin and Crispr are three stocks to watch for potentially higher prices
Someone on ST posted that the bid was $25 and the ask is $26.27.
I might be in an order to sell a few shares at $30 and $35.